Caricamento...
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
INTRODUCTION: Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed. M...
Salvato in:
| Pubblicato in: | Alzheimers Dement (Amst) |
|---|---|
| Autori principali: | , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087978/ https://ncbi.nlm.nih.gov/pubmed/33969172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12179 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|